Molecular Radiotherapy Comes of Age

Affiliations

¹ Weston Park Cancer Centre, Sheffield, UK. Electronic address: jonathan.wadsley1@nhs.net.
² Royal Marsden NHS Foundation Trust, Sutton, UK.

Editorial

J Wadsley et al. Clin Oncol (R Coll Radiol). 2021 Feb.

. 2021 Feb;33(2):65-67.

doi: 10.1016/j.clon.2020.12.004. Epub 2020 Dec 17.

¹ Weston Park Cancer Centre, Sheffield, UK. Electronic address: jonathan.wadsley1@nhs.net.
² Royal Marsden NHS Foundation Trust, Sutton, UK.

No abstract available

Comment on

Controversies in Radioiodine Treatment of Low- and Intermediate-risk Thyroid Cancer.
Eilsberger F, Verburg FA. Eilsberger F, et al. Clin Oncol (R Coll Radiol). 2021 Feb;33(2):68-74. doi: 10.1016/j.clon.2020.11.009. Epub 2020 Nov 26. Clin Oncol (R Coll Radiol). 2021. PMID: 33250287
Prospects for Personalised Treatment of Patients with Radioiodine-avid Locally Recurrent or Metastatic Thyroid Cancer.
Beasley M, Garcez K. Beasley M, et al. Clin Oncol (R Coll Radiol). 2021 Feb;33(2):75-79. doi: 10.1016/j.clon.2020.11.010. Epub 2020 Dec 16. Clin Oncol (R Coll Radiol). 2021. PMID: 33339681 Review.